Skip to main content
SpringerLink
Log in

Effects of inflammation products on immune systems

Lysophosphatidylcholine stimulates macrophages

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Microbial infection causes inflammation which stimulates macrophage functions. One of the inflammatory products, lysophosphatidylcholine (lyso-Pc), can stimulate macrophage activities. Treatment of mice with lyso-Pc enhanced spreading and ingestion activities of peritoneal macrophages. In vitro treatment of macrophages with lyso-Pc greatly enhanced spreading but not ingestion activities. However, incubation of a mixture of adherent and nonadherent cells with lyso-Pc produced a markedly enhanced ingestion activity of macrophages, implying the contribution of nonadherent cells to the stimulation of macrophages. Time course studies of the stimulation of these macrophages showed that spreading activity is stimulated immediately, even 30 min, after their contact with lyso-Pc while induction of ingestion activity requires a latent period of about 5 h. When the specificity of the macrophage receptors for ingestion was analyzed using defined immunoglobulins (i.e., IgG and IgM) with or without complement, lyso-Pc-activated macrophages efficiently ingested IgG-coated sheep erythrocytes independent of complement. However, macrophages of the same lyso-Pc-treated mice did not ingest erythrocytes coated with IgM and complement. These observations suggest that lyso-Pc-stimulated macrophages ingest the targets via Fc-receptors but not C3b receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andreesen R, Modolell M, Weltizien HU, Eibl H, Common HH, Lohr GW, Munder PG (1978) Selective destruction of human leukemic cells by alkyl lysophospholipids. Cancer Res 38:3894

    Google Scholar 

  2. Berdel WE, Fink U, Egger B, Reichert A, Munder PG, Rastetter J (1981) Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors. J Natl Cancer Inst 66:813

    Google Scholar 

  3. Berdel WE, Greiner E, Fink M, Stavrou D, Reichert A, Rastetter J, Snyder F (1982) Cytotoxic effect of alkyl-lysophospholipids (ALP) in rat brain tumor cells. Proc Am Soc Cancer Res p 198 No. 782

  4. Berdel WE, Fink U, Rastetter J (1982) Phase I study of alkyl-lysophospholipids (ALP) in advanced malignant disease. Proc Am Soc Clin Oncol p 18, No C71

  5. Bianco C, Griffin FM, Silverstein SC (1975) Studies of macrophage complement receptors. Alteration of receptor function upon macrophage activation. J Exp Med 141:1278

    Google Scholar 

  6. Bianco C, Eden AA, Cohn AZ (1976) The induction of macrophage spreading: role of coagulation factors and the complement system. J Exp Med 144:1531

    Google Scholar 

  7. Chien KR, Abrams J, Serioni A, Martin JT, Farber JL (1978) Accelerated phospholipid degradation and associated membrane dysfunction in irreversible ischemic liver cell inury. J Biol Chem 253:4809

    Google Scholar 

  8. Chon ZA, Benson B (1975) The differentiation of mononuclear phagocytes, morphology, cytochemistry, and biochemistry. J Exp med 121:153

    Google Scholar 

  9. Davidson I, Nelson DA (1969) The blood. In: Davidson I, Henry JB (eds) Todd-Sanford Clinical diagnosis by laboratory methods 14th edn. W. B. Sauners Company, Philadelphia, p 120

    Google Scholar 

  10. Doe WF, Henson PM (1978) Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells. J Exp Med 148:544

    Google Scholar 

  11. Elin RJ, Wolff SM, Cheolid L (1976) Non-specific resistance to infection induced in mice by a water soluble adjuvant derived from Mycobacterium smegmatis J Infect Dis 133:500

    Google Scholar 

  12. Gillett MPT, Besterman EMM (1975) Plasma concentration of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerosis diseases. Atherosclerosis 22:111

    Google Scholar 

  13. Goerke J, deGier J, Bensen PPM (1971) Silica gel stimulates the hydrolysis of lecithin by phospholipase A. Biochim Biophys Acta 248:245

    Google Scholar 

  14. Griffin FM, Silverstein SC (1974) Segmental response of the macrophages plasma membrane to a phagocytic stimulus. J Exp Med 139:323

    Google Scholar 

  15. Hoerni B, Durand M, Richard P, deMascarel A, Hoerni-Simon G, Chauvegne J, Lagarde C (1979) Successful maintenance immunotherapy by BCG of non-Hidgkin's Malignant lymphomas: Results of controlled trail. Br J Haematol 42:507

    Google Scholar 

  16. Hoerni B, Durand M, Eghbali H, Hoerni-simon G, Richard P, deMascarel A (1982) Maintenance immunotherapy with BCG in non-Hodgkin's malignant lymphomas: A progress report of a randomized trial. In: Mathe G, Bonadonna G, Salmon S (eds) Adjuvant therapies of cancer. Springer-Verlag, Berlin, Heidelberg, New York, p 92

    Google Scholar 

  17. Le Mevel BP (1982) Ewing's Sarcoma: 5 year survival under adjuvant chemotherapy. In: Mathe G, Bonadonna G, Salmon S (eds) Adjuvant therapies of cancer. Springer-Verlag, Berlin, Heidelberg, New York, p 128

    Google Scholar 

  18. Lowe J, Shore DF, Iles PB, Langman MJS, Baldwin RW (1980) Intrapleural BCG in operable lung cancer. Lancet I:11

    Google Scholar 

  19. Mantovani B, Robinovitch M, Nussenszweig V (1972) Phagocytosis of murine complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG) J Exp Med 135:780

    Google Scholar 

  20. McKneally MF, Maver C, Kausel HW (1976) Regional immunotherapy of lung cancer with intrapleural BCG. Lancet I:377

    Article  Google Scholar 

  21. Modell M, Munder PG (1972) The action of purified phospholipase B in inflammation and immunity. Int Arch Allergy 43:724

    Google Scholar 

  22. Munder PG, Modelell M, Ferber E, Fischer H (1970) The relationship between macrophages and adjuvants activity. In: Furth R (ed) Mononuclear phagocytes. Blackwell Scientific Publications, Oxford, p 445

    Google Scholar 

  23. Munder PG, Fischer H, Weltzien HU, Oettgen HW, Westphal O (1976) Lysolecithin analogs: a new class of immunopotentiators with antitumor activity. Proc Am Assoc Cancer Res 17:174

    Google Scholar 

  24. Munder PG, Modelell M, Andreesen R, Weltzien HU, Westphal O (1980) Lysophosphatidylcholine (Lysolecithin) and its synthetic analogs, immunomodulating and other biological effects. In: Chedid L, Miescher PA, Mueller-Eberhard HJ (eds) Immunomodulating: Springer Semin Immunopath Vol 2 No 1–2. Springer-Verlag, Berlin P 177

    Google Scholar 

  25. Neumann C, Sorg C (1980) Sequential expression of functions during macrophage differentiation in murine bone marrow liquid cultures. Eur J Immunol 10:834

    Google Scholar 

  26. Newman SL, Musson RA, Henson PM (1980) Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J Immunol 125:2236

    Google Scholar 

  27. Ngwenya BZ, Yamamoto N (1985) Activation of peritoneal macrophages by lysophosphatidylcholine. Biochim Biophys Acta 839:9

    Google Scholar 

  28. Ottolenghi A, Kocan AA, Weatherly NF, Larsh JE (1975) Nipposdtrongylus brasiliensis: Phospholipase in nonsensitized and sensitized rats after challenge. Exp Parasitol 38:96

    Google Scholar 

  29. Rapp HJ (1976) Immunotherapy of experimental cancer with BCG. In: Crowell RL, Friedman H, Prier JE (eds) Tumor virus infections and immunity. University Park Press, Baltimore p 261

    Google Scholar 

  30. Runge MH, Andreesen R, Pfleideres A, Munder PG (1980) Destruction of human solid tumors by alkyl-lysophospholipids. J Natl Cancer Inst 64:1301

    Google Scholar 

  31. Saluk PH, Edmundowicz S, Wrighley DM, Tabor DR (1981) Co-expression of enhanced spreading, ingestion, and inhibition of tumor cell proliferation by macrophages from lipopolysaccharide injected mice. Cancer Immunol Immunother 11:159

    Google Scholar 

  32. Senn HJ, Amgwerd R, Jungi WF, Hochuli R, Ammann J, Engelhart G, Heinz C, Wick A, Enderlin F, Greux G, Simon B, Lanz R, Bigler R, Seiler S (1982) Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer-intermediate report at 4 years. In: Mathe G, Bonadonna G, Salmon S (eds) Adjuvant therapies of cancer. Springer-Verlag, Berlin, Heidelberg, New York p 177

    Google Scholar 

  33. Snyder F, Maline B, Piantodosi C (1973) Tetrahydropteridine-dependent cleavage enzyme for O-alkyl-lipids: substrate specificity. Biochim Biophys Acta 316:259

    Google Scholar 

  34. Soodsma JF, Piantodosi C, Snyder F (1970) The biocleavage of aklyl-glyceryl ethers in Morris hepatomas and other transplantable neoplasms. Cancer Res 30:309

    Google Scholar 

  35. Tabor DR, Saluk PH (1981) The functional heterogenecity of murine-resident macrophages to a chemotactic signal and induction of C3b receptor-mediated ingestion. Immunol Lett 3:371

    Google Scholar 

  36. White RG, Coons HH, Connally JM (1955) Studies on antibody production III. The alum granuloma. J Exp Med 102:73

    Google Scholar 

  37. Wrigley DM, Saluk PH (1981) Induction of C3b-mediated phagocytosis in macrophages by distinct populations of lipopolysaccharide-stimulated lymphocytes. Infect, Immun 34:780

    Google Scholar 

  38. Yamamoto N, Kawada K, Ochiai H, Droffner ML, Ngwenya BZ (1983) Activation of macrophages by lysophosphatidylcholine and their analogs. Abst Am Soc Microbiol, p 25

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Hahnemann University School of Medicine, 19102, Philadelphia, PA, USA

    Benjamim Z. Ngwenya & Nobuto Yamamoto

Authors
  1. Benjamim Z. Ngwenya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuto Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ngwenya, B.Z., Yamamoto, N. Effects of inflammation products on immune systems. Cancer Immunol Immunother 21, 174–182 (1986). https://doi.org/10.1007/BF00199358

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199358

Keywords

Search

Navigation